Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

about

Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview

P2860

Q26822792-3B5660F6-207D-4497-B59C-30965B65B7DA

P2860

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

Item

http://www.wikidata.org/entity/Q36216989

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

@ast

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

@en

type

Item

label

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

@ast

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

@en

prefLabel

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

@ast

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

@en

P1476

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

@en

P2093

Hyeong-Rok Kim

http://www.w3.org/2001/XMLSchema#string

Ji-Shin Lee

http://www.w3.org/2001/XMLSchema#string

Ju-Young Song

http://www.w3.org/2001/XMLSchema#string

Mee Sun Yoon

http://www.w3.org/2001/XMLSchema#string

Sung-Ja Ahn

http://www.w3.org/2001/XMLSchema#string

Taek-Keun Nam

http://www.w3.org/2001/XMLSchema#string

P2860

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

Interaction between the retinoblastoma protein and the oncoprotein MDM2

The retinoblastoma protein and cell cycle control

p53, the cellular gatekeeper for growth and division

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.

The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours.

The role of DNA mismatch repair in drug resistance.

P304

23-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL_00000004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230830751

http://www.w3.org/2001/XMLSchema#string

P698

22966250

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3436461

http://www.w3.org/2001/XMLSchema#string

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

about

P2860

P2860

Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932